BMRN vs GCT · P/E 40, rev $1.76B vs P/E 6.9, rev $1.29B
Biomarin Pharmaceutical Inc (BMRN) versus GigaCloud Technology Inc Class A Ordinary Shares (GCT) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
GigaCloud Technology Inc Class A Ordinary Shares (GCT) is a software - infrastructure company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported GCT revenue for 2025-12-31 was $1.29B. Net income was $137.4M. Revenue was up 11.1% from 2024-12-31 to 2025-12-31. GCT currently screens at market cap $830.9M and trailing P/E 6.9.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. GCT currently screens at market cap $830.9M and trailing P/E 6.9.
Not investment advice. Open the BMRN and GCT stock pages for the full models.
Not investment advice.